Cargando…
Polymorphism of 9p21.3 Locus Is Associated with 5-Year Survival in High-Risk Patients with Myocardial Infarction
OBJECTIVE: The rs10757278, rs1333049 and rs4977574 are single nucleotide polymorphisms (SNPs) of chromosome 9p21 locus associated with a prevalence of acute coronary syndromes (ACS). Reports concerning their association with long-term outcome after an ACS are equivocal. The aim of our study was to i...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126747/ https://www.ncbi.nlm.nih.gov/pubmed/25105296 http://dx.doi.org/10.1371/journal.pone.0104635 |
_version_ | 1782329960023719936 |
---|---|
author | Szpakowicz, Anna Kiliszek, Marek Pepinski, Witold Waszkiewicz, Ewa Franaszczyk, Maria Skawronska, Małgorzata Ploski, Rafal Niemcunowicz-Janica, Anna Dobrzycki, Sławomir Opolski, Grzegorz Musial, Włodzimierz Jerzy Kaminski, Karol Adam |
author_facet | Szpakowicz, Anna Kiliszek, Marek Pepinski, Witold Waszkiewicz, Ewa Franaszczyk, Maria Skawronska, Małgorzata Ploski, Rafal Niemcunowicz-Janica, Anna Dobrzycki, Sławomir Opolski, Grzegorz Musial, Włodzimierz Jerzy Kaminski, Karol Adam |
author_sort | Szpakowicz, Anna |
collection | PubMed |
description | OBJECTIVE: The rs10757278, rs1333049 and rs4977574 are single nucleotide polymorphisms (SNPs) of chromosome 9p21 locus associated with a prevalence of acute coronary syndromes (ACS). Reports concerning their association with long-term outcome after an ACS are equivocal. The aim of our study was to investigate the association of the 9p21.3 locus with 5-year overall mortality in patients with ST-elevation myocardial infarction (STEMI). MATERIALS AND METHODS: We performed a retrospective analysis of data collected prospectively in 2 independent registries of consecutive patients with STEMI (derivation and validation group). Genotyping was performed with the TaqMan method. The analyzed end-point was total mortality. RESULTS: The derivation group comprised 589 patients: 25.3% female (n = 149), mean age 62.4±12.0 years, total 5-year mortality 16.6% (n = 98). When all the study group was analyzed, no significant differences in mortality were found between the genotypes. However, in high-risk patients (GRACE risk score ≥155 points, n = 238), homozygotes associated with higher risk for ACS had significantly better 5-year survival compared to other genotypes. The hazard ratio associated with the high-risk genotype (a homozygote of high risk for ACS or a heterozygote) was: HR = 2.2 (1.15–4.2) for the rs10757278 polymorphism, HR = 2.7 (95% CI 1.3–5.4) for the rs4977574 one and HR = 2.3 (1.2–4.5) for the rs1333049 one (Cox proportional hazards model). Survival analysis in the validation group (n = 365) showed a clear trend towards better prognosis in GG homozygotes of the rs10757278 SNP, which confirms our initial results (p = 0.09, log-rank test). CONCLUSIONS: The 9p21.3 locus is associated with 5-year mortality in high-risk patients with STEMI. The genotypes associated with higher risk for ACS show a protective effect in terms of further survival (instead of a deteriorating prognosis, as reported previously). This finding, due to the very high size of the effect, could potentially be applied to clinical practice, if appropriate methods are elaborated. |
format | Online Article Text |
id | pubmed-4126747 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-41267472014-08-12 Polymorphism of 9p21.3 Locus Is Associated with 5-Year Survival in High-Risk Patients with Myocardial Infarction Szpakowicz, Anna Kiliszek, Marek Pepinski, Witold Waszkiewicz, Ewa Franaszczyk, Maria Skawronska, Małgorzata Ploski, Rafal Niemcunowicz-Janica, Anna Dobrzycki, Sławomir Opolski, Grzegorz Musial, Włodzimierz Jerzy Kaminski, Karol Adam PLoS One Research Article OBJECTIVE: The rs10757278, rs1333049 and rs4977574 are single nucleotide polymorphisms (SNPs) of chromosome 9p21 locus associated with a prevalence of acute coronary syndromes (ACS). Reports concerning their association with long-term outcome after an ACS are equivocal. The aim of our study was to investigate the association of the 9p21.3 locus with 5-year overall mortality in patients with ST-elevation myocardial infarction (STEMI). MATERIALS AND METHODS: We performed a retrospective analysis of data collected prospectively in 2 independent registries of consecutive patients with STEMI (derivation and validation group). Genotyping was performed with the TaqMan method. The analyzed end-point was total mortality. RESULTS: The derivation group comprised 589 patients: 25.3% female (n = 149), mean age 62.4±12.0 years, total 5-year mortality 16.6% (n = 98). When all the study group was analyzed, no significant differences in mortality were found between the genotypes. However, in high-risk patients (GRACE risk score ≥155 points, n = 238), homozygotes associated with higher risk for ACS had significantly better 5-year survival compared to other genotypes. The hazard ratio associated with the high-risk genotype (a homozygote of high risk for ACS or a heterozygote) was: HR = 2.2 (1.15–4.2) for the rs10757278 polymorphism, HR = 2.7 (95% CI 1.3–5.4) for the rs4977574 one and HR = 2.3 (1.2–4.5) for the rs1333049 one (Cox proportional hazards model). Survival analysis in the validation group (n = 365) showed a clear trend towards better prognosis in GG homozygotes of the rs10757278 SNP, which confirms our initial results (p = 0.09, log-rank test). CONCLUSIONS: The 9p21.3 locus is associated with 5-year mortality in high-risk patients with STEMI. The genotypes associated with higher risk for ACS show a protective effect in terms of further survival (instead of a deteriorating prognosis, as reported previously). This finding, due to the very high size of the effect, could potentially be applied to clinical practice, if appropriate methods are elaborated. Public Library of Science 2014-08-08 /pmc/articles/PMC4126747/ /pubmed/25105296 http://dx.doi.org/10.1371/journal.pone.0104635 Text en © 2014 Szpakowicz et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Szpakowicz, Anna Kiliszek, Marek Pepinski, Witold Waszkiewicz, Ewa Franaszczyk, Maria Skawronska, Małgorzata Ploski, Rafal Niemcunowicz-Janica, Anna Dobrzycki, Sławomir Opolski, Grzegorz Musial, Włodzimierz Jerzy Kaminski, Karol Adam Polymorphism of 9p21.3 Locus Is Associated with 5-Year Survival in High-Risk Patients with Myocardial Infarction |
title | Polymorphism of 9p21.3 Locus Is Associated with 5-Year Survival in High-Risk Patients with Myocardial Infarction |
title_full | Polymorphism of 9p21.3 Locus Is Associated with 5-Year Survival in High-Risk Patients with Myocardial Infarction |
title_fullStr | Polymorphism of 9p21.3 Locus Is Associated with 5-Year Survival in High-Risk Patients with Myocardial Infarction |
title_full_unstemmed | Polymorphism of 9p21.3 Locus Is Associated with 5-Year Survival in High-Risk Patients with Myocardial Infarction |
title_short | Polymorphism of 9p21.3 Locus Is Associated with 5-Year Survival in High-Risk Patients with Myocardial Infarction |
title_sort | polymorphism of 9p21.3 locus is associated with 5-year survival in high-risk patients with myocardial infarction |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126747/ https://www.ncbi.nlm.nih.gov/pubmed/25105296 http://dx.doi.org/10.1371/journal.pone.0104635 |
work_keys_str_mv | AT szpakowiczanna polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction AT kiliszekmarek polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction AT pepinskiwitold polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction AT waszkiewiczewa polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction AT franaszczykmaria polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction AT skawronskamałgorzata polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction AT ploskirafal polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction AT niemcunowiczjanicaanna polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction AT dobrzyckisławomir polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction AT opolskigrzegorz polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction AT musialwłodzimierzjerzy polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction AT kaminskikaroladam polymorphismof9p213locusisassociatedwith5yearsurvivalinhighriskpatientswithmyocardialinfarction |